Variant-adapted COVID vaccine wins first approval in Britain
- Country:
- United Kingdom
Britain has become the first country to approve a COVID-19 vaccine that targets both the original and Omicron variant of the virus.
The vaccine, made by U.S. drug company Moderna, has been approved by UK health officials as a booster for adults, the UK medicines regulator said on Monday.
ALSO READ
-
Screwworm Resurgence Threatens U.S.-Mexico Livestock Trade
-
Britain Seeks Inclusion in EU's 'Made in Europe' Policy
-
Prince Harry's Return to Britain and Spotlight on Invictus Spirit Awards
-
India Defends Energy Policy Amidst Rising Tariff Threats from U.S.
-
Unleashing Market Forces: The Path to Reviving Britain's High Streets
Google News